A study reveals economic inequality is a key predictor of pandemic response effectiveness, urging nations to prioritize ...

Experts have urged those who already received their first injection of the twice-yearly HIV preventing drug Lenacapavir to consider using combination prevention options, warning that the game changer ...

Disruptions to funding and new policies aimed at aligning foreign aid programs with the Trump administration’s agenda have ...

Among healthcare providers, 89% (n=16/18) reported a positive overall opinion of administering CAB LA for PrEP in their practice. Prescribers cited benefits of regular injection visits, including ...

Around 77,000 fewer children worldwide received HIV treatment supported by the U.S. since October 2025 than in the previous ...

Economic inequality is the clearest way to predict how countries will fare during a pandemic, a high-profile panel said ...

Researchers at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage ...

Dovato is indicated for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg in the EU, and weighing at least ...

People with hearing loss who received a hearing-aid prescription faced a 5.0 percent chance of developing dementia over seven ...

ViiV Healthcare’s Dovato has been approved for use in the US and EU since 2019, but its sales remain overshadowed by Gilead’s Biktarvy.

ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced today that it will make three ...

A new research study examining the scale of disruptions to HIV programmes caused by funding cuts from the United States’ ...